ADBE vs TMO: Which Is the Better Buy?
Side-by-side comparison of Adobe Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Adobe Inc. · Technology
$195.16
+45.0% upside to fair value
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
ADBE has more upside to fair value
(+45.0%).
ADBE trades at a lower forward P/E
(11.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ADBE |
TMO |
| Current Price |
$195.16 |
$464.61 |
| Fair Value Estimate |
$282.98 |
$498.27 |
| Upside to Fair Value |
+45.0%
|
+7.2%
|
| Market Cap |
$77.6B |
$172.7B |
| Forward P/E |
11.2x
|
25.2x
|
| EV / EBITDA |
8.0x
|
19.1x
|
| Price / Sales |
3.1x
|
3.8x
|
| Price / FCF |
7.3x
|
25.6x
|
| Revenue Growth YoY |
+12.7%
|
+6.2%
|
| Gross Margin |
89.1%
|
39.4%
|
| Operating Margin |
36.1%
|
17.8%
|
| Return on Equity |
62.4%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
13.7%
|
3.91%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Adobe Inc. is a leading technology company specializing in software applications for digital media creation and digital document workflows. The business quality is high, supported by durable competitive moats including workflow entrenchment, format standards, and subscription switching costs. Adobe's strong financials include a trailing P/E of 11.15, a forward P/E of 11.15, and a P/FCF of 7.3, in…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
ADBE |
TMO |
| Zone Low |
$212.24 |
$373.70 |
| Zone High |
$240.53 |
$423.53 |
| In Buy Zone? |
Yes
|
No
|